Kimberley A. Lentz

2.1k total citations
24 papers, 963 citations indexed

About

Kimberley A. Lentz is a scholar working on Oncology, Pharmaceutical Science and Molecular Biology. According to data from OpenAlex, Kimberley A. Lentz has authored 24 papers receiving a total of 963 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Oncology, 9 papers in Pharmaceutical Science and 6 papers in Molecular Biology. Recurrent topics in Kimberley A. Lentz's work include Drug Transport and Resistance Mechanisms (10 papers), Drug Solubulity and Delivery Systems (8 papers) and Chemical Synthesis and Analysis (4 papers). Kimberley A. Lentz is often cited by papers focused on Drug Transport and Resistance Mechanisms (10 papers), Drug Solubulity and Delivery Systems (8 papers) and Chemical Synthesis and Analysis (4 papers). Kimberley A. Lentz collaborates with scholars based in United States, Germany and Netherlands. Kimberley A. Lentz's co-authors include James E. Polli, Feng Qian, Erik Rytting, Joan E. Humphreys, Joseph W. Polli, Stephen A. Wring, Dean Y. Maeda, Andrew Coop, Jaquan K. Levons and Jun Hayashi and has published in prestigious journals such as Journal of Medicinal Chemistry, International Journal of Pharmaceutics and Pharmaceutical Research.

In The Last Decade

Kimberley A. Lentz

24 papers receiving 919 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Kimberley A. Lentz United States	14	323	305	199	139	136	24	963
Robert A. Carr United States	19	338 1.0×	191 0.6×	193 1.0×	128 0.9×	156 1.1×	41	986
Lori H. Takahashi United States	12	293 0.9×	473 1.6×	449 2.3×	171 1.2×	93 0.7×	17	1.3k
Viera Lukáčová United States	18	184 0.6×	234 0.8×	371 1.9×	109 0.8×	51 0.4×	56	951
David Dahlgren Sweden	20	498 1.5×	435 1.4×	247 1.2×	88 0.6×	48 0.4×	43	1.1k
Gloria Y. Kwei United States	14	214 0.7×	324 1.1×	339 1.7×	118 0.8×	60 0.4×	28	1.2k
Aki T. Heikkinen Finland	18	211 0.7×	317 1.0×	215 1.1×	109 0.8×	65 0.5×	34	819
Anand Balakrishnan United States	20	196 0.6×	458 1.5×	345 1.7×	63 0.5×	83 0.6×	36	1.2k
H. Spahn‐Langguth Germany	15	389 1.2×	526 1.7×	265 1.3×	118 0.8×	74 0.5×	43	1.2k
Shiyin Yee United States	9	213 0.7×	259 0.8×	447 2.2×	99 0.7×	36 0.3×	13	1.2k
Sekhar Surapaneni United States	19	323 1.0×	297 1.0×	524 2.6×	198 1.4×	306 2.3×	52	1.8k

Countries citing papers authored by Kimberley A. Lentz

Since Specialization

Citations

This map shows the geographic impact of Kimberley A. Lentz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kimberley A. Lentz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kimberley A. Lentz more than expected).

Fields of papers citing papers by Kimberley A. Lentz

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kimberley A. Lentz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kimberley A. Lentz. The network helps show where Kimberley A. Lentz may publish in the future.

Co-authorship network of co-authors of Kimberley A. Lentz

This figure shows the co-authorship network connecting the top 25 collaborators of Kimberley A. Lentz. A scholar is included among the top collaborators of Kimberley A. Lentz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kimberley A. Lentz. Kimberley A. Lentz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

1.

Zhuo, Xiaoliang, Brett A. Howell, Hong Shen, et al.. (2023). Mechanistic investigation of liver injury induced by BMS-932481, an experimental ɣ-secretase modulator. Toxicological Sciences. 194(2). 235–245. 4 indexed citations

2.

Guarino, Victor R., Richard E. Olson, Ivar M. McDonald, et al.. (2019). An amide-based sulfenamide prodrug of gamma secretase inhibitor BMS–708163 delivers parent drug from an oral conventional solid dosage form in male beagle dog. Bioorganic & Medicinal Chemistry Letters. 30(3). 126856–126856. 8 indexed citations

3.

Narang, Ajit S., Anand Balakrishnan, J. S. Morrison, et al.. (2017). Role of regional absorption and gastrointestinal motility on variability in oral absorption of a model drug. European Journal of Pharmaceutics and Biopharmaceutics. 117. 333–345. 5 indexed citations

4.

Martinez, Marilyn N., Bipin Mistry, Kimberley A. Lentz, et al.. (2017). Exploring Canine-Human Differences in Product Performance. Part II: Use of Modeling and Simulation to Explore the Impact of Formulation on Ciprofloxacin In Vivo Absorption and Dissolution in Dogs. The AAPS Journal. 19(3). 712–726. 4 indexed citations

5.

Zuev, Dmitry, Li Xu, Kimberley A. Lentz, et al.. (2015). Design and optimization of tricyclic gamma-secretase modulators. Bioorganic & Medicinal Chemistry Letters. 26(5). 1498–1502. 11 indexed citations

6.

Wu, Yong‐Jin, Yunhui Zhang, Weixu Zhai, et al.. (2015). Macrocyclic prolinyl acyl guanidines as inhibitors of β-secretase (BACE). Bioorganic & Medicinal Chemistry Letters. 25(22). 5040–5047. 13 indexed citations

7.

Hu, Shuanghua, Yong‐Jin Wu, Huan He, et al.. (2014). Structure activity relationship studies of 3-arylsulfonyl-pyrido[1,2-a]pyrimidin-4-imines as potent 5-HT6 antagonists. Bioorganic & Medicinal Chemistry. 22(5). 1782–1790. 17 indexed citations

8.

Cheng, Kunrong, Sandeep Khurana, Su Xu, et al.. (2013). Design and Characterization of a Novel Fluorinated Magnetic Resonance Imaging Agent for Functional Analysis of Bile Acid Transporter Activity. Pharmaceutical Research. 30(5). 1240–1251. 10 indexed citations

9.

Luo, Guanglin, Ling Chen, Charles M. Conway, et al.. (2012). Discovery of BMS-846372, a Potent and Orally Active Human CGRP Receptor Antagonist for the Treatment of Migraine. ACS Medicinal Chemistry Letters. 3(4). 337–341. 32 indexed citations

10.

Whiterock, Valerie, et al.. (2011). Phenacetin Pharmacokinetics in CYP1A2-Deficient Beagle Dogs. Drug Metabolism and Disposition. 40(2). 228–231. 11 indexed citations

11.

Toyn, Jeremy H., Jere E. Meredith, Donna M. Barten, et al.. (2011). Monosubstituted γ-lactam and conformationally constrained 1,3-diaminopropan-2-ol transition-state isostere inhibitors of β-secretase (BACE). Bioorganic & Medicinal Chemistry Letters. 21(22). 6916–6924. 16 indexed citations

12.

Gu, Chong‐Hui, Hua Li, Jaquan K. Levons, et al.. (2007). Predicting Effect of Food on Extent of Drug Absorption Based on Physicochemical Properties. Pharmaceutical Research. 25(4). 979–979. 6 indexed citations

13.

Gu, Chong‐Hui, Hua Li, Jaquan K. Levons, et al.. (2007). Predicting Effect of Food on Extent of Drug Absorption Based on Physicochemical Properties. Pharmaceutical Research. 24(6). 1118–1130. 115 indexed citations

14.

Lentz, Kimberley A., et al.. (2006). Development and Validation of a Preclinical Food Effect Model. Journal of Pharmaceutical Sciences. 96(2). 459–472. 63 indexed citations

15.

Gupta, E, D.M. Barends, Kimberley A. Lentz, et al.. (2006). Review of global regulations concerning biowaivers for immediate release solid oral dosage forms. European Journal of Pharmaceutical Sciences. 29(3-4). 315–324. 51 indexed citations

16.

Rytting, Erik, et al.. (2005). Aqueous and cosolvent solubility data for drug-like organic compounds. The AAPS Journal. 7(1). E78–E105. 98 indexed citations

17.

Rytting, Erik, et al.. (2004). A Quantitative Structure-Property Relationship for Predicting Drug Solubility in PEG 400/Water Cosolvent Systems. Pharmaceutical Research. 21(2). 237–244. 41 indexed citations

18.

Lentz, Kimberley A., et al.. (2003). Increased Acyclovir Oral Bioavailability via a Bile Acid Conjugate. Molecular Pharmaceutics. 1(1). 40–48. 102 indexed citations

19.

Lentz, Kimberley A., Joseph W. Polli, Stephen A. Wring, Joan E. Humphreys, & James E. Polli. (2000). Influence of Passive Permeability on Apparent P-glycoprotein Kinetics. Pharmaceutical Research. 17(12). 1456–1460. 105 indexed citations

20.

Lentz, Kimberley A., et al.. (2000). Development of a more rapid, reduced serum culture system for Caco-2 monolayers and application to the biopharmaceutics classification system. International Journal of Pharmaceutics. 200(1). 41–51. 67 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact